Faculty Opinions Recommendation of 1113P COLUMBUS 7-Year Update: A Randomized, Open-Label, Phase III Trial of Encorafenib (enco) + Binimetinib (bini) Vs Vemurafenib (vemu) or Enco in Patients (pts) with BRAF V600–mutant Melanoma.
openalex（2023）
关键词
Melanoma
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要